Xoma | XOMA - Dochód Netto





Dochód Netto Zmiana Data
AbbVie USD 695M 1.12B 2026-03
Agenus USD -10.63M 74.49M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Ardelyx USD -37.6M 37.2M 2026-03
aTyr Pharma USD -153K 24.71M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Celldex Therapeutics USD -78.68M 2.63M 2026-03
Curis USD 19.36M 31.16M 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Incyte USD 303.33M 4.05M 2026-03
MacroGenics USD -36.77M 22.62M 2026-03
Novartis USD 3.16B 747M 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Prothena USD 32.72M 54.31M 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Xoma USD -17.24M 33.23M 2024-09